applications
what FSL constructs are used for
FSL constructs label cells, viruses, liposomes and surfaces in minutes, with no genetic change. That one method is now used in blood services, virology, research labs, glycobiology and therapeutics. The key published papers for each use are listed below.
Kode Technology in diagnostics and transfusion medicine
Kodecytes, red cells carrying FSL constructs, give laboratories reagent cells with a defined antigen at a controlled level. They run on the blood-grouping analysers laboratories already use.
Blood-group reagent cells
A and B FSL constructs create artificial ABO subgroups at a controlled antigen density. Peptide FSL constructs create rare screening cells, such as MUT+Mur and Miltenberger kodecytes.
Key papers
- Synthetic glycolipid modification of red blood cell membranesFrame et al., Transfusion, 2007
- Flow cytometry evaluation of red blood cells mimicking naturally-occurring ABO subgroupsHult et al., Transfusion, 2012
- Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto erythrocytesHeathcote et al., Transfusion, 2010
- Designing peptide-based FSL constructs to create Miltenberger kodecytesHenry et al., ISBT Science Series, 2011
Antibody specificity and quantitation
Defined synthetic glycans on kodecytes map the fine specificity of anti-A, anti-B and anti-A,B. They also measure ABO antibodies in undiluted plasma before ABO-incompatible kidney transplantation.
Key papers
- Revealing and quantifying polyclonal anti-A,B specificity in ABO histo-blood groupsHenry et al., Transfusion, 2026
- Chemical resolution of an epitope recognized by blood group antibodies capable of binding both A and B red blood cellsObukhova et al., ChemBioChem, 2024
- A standardized kodecyte method to quantify ABO antibodies in undiluted plasma before ABO-incompatible kidney transplantationPerry et al., Transfusion, 2019
Quality control and proficiency testing
Engineered antigen levels give graded positive controls, ABO sensitivity controls and specimens for external proficiency testing.
Key papers
- Modification of red blood cells for laboratory quality control useHenry, Current Opinion in Hematology, 2009
- Evaluation of kodecytes as a survey material for external proficiency testing for ABO subgroupingLim and Kang, J Clin Lab Analysis, 2017
Teaching and competency
Reactions of known strength and specificity support student training panels and serologic grading exercises.
Key papers
- Simulated red cell antibody identification training panels created using SARS-CoV-2 kodecytesPerry and Henry, Transfusion, 2022
- Training students in serologic reaction gradingPerry and Henry, Transfusion, 2015
Transfusion reaction models
Antigen-engineered red cells model how antibody, complement and antigen density affect red-cell survival and antibody neutralisation.
Key papers
- Modeling transfusion reactions and predicting in vivo cell survival with kodecytesOliver et al., Transfusion, 2011
- In vivo neutralization of anti-A and successful transfusion of A antigen incompatible red cells in an animal modelOliver et al., Transfusion, 2011
Infection serology on blood-bank analysers
Peptide kodecytes detected SARS-CoV-2 and syphilis antibodies on routine column-agglutination analysers, in studies of donor samples. Blood services could use the same equipment for population surveillance.
Key papers
- COVID-19 antibody screening with SARS-CoV-2 red cell kodecytes using routine serologic diagnostic platformsNagappan et al., Transfusion, 2021
- Using SARS-CoV-2 red cell kodecytes to assess vaccine-induced immune response in Indian blood donorsDatta et al., Transfusion Clinique et Biologique, 2025
- A novel syphilis Treponema pallidum lipoprotein peptide antigen diagnostic assay using red cell kodecytesDatta et al., Vox Sanguinis, 2024
- Continuous population surveillance of COVID-19 immunity can be provided by blood services at low costHenry et al., Blood Transfusion, 2022
Immunoglobulin potency testing
CMV-peptide kodecytes measure the Fc function of immunoglobulin products through complement activation. It is a product quality test, not a donor screening test.
Key paper
- An improved Fc function assay utilising CMV antigen coated red blood cells generated with synthetic FSL constructsGeorgakopoulos et al., Vox Sanguinis, 2012
In use: Securacell™ quality controls
Immulab's Securacell™ and Securacell™ Light immunohaematology process controls use KODE™ CA (carbohydrate antigen) technology to provide group A weak and B weak cells. They are whole-blood samples tested alongside patient samples to control ABO and RhD grouping, antibody screening, ABO sensitivity and staff competency (Immulab product catalogue, p.4). Immulab productsKode Technology in virology and infectious diseases
FSL constructs insert into the membrane of enveloped viruses, so intact virions can be labelled without changing their proteins. Labelled viruses are called kodevirions.
Virus receptor-binding assays
FSL-biotin gives virions a universal detection handle in capture ELISAs. Recent hantavirus receptor studies used it, including a 2026 paper in Nature.
Key papers
- Structural basis for protocadherin-1 recognition by New World hantavirusesBattini et al., Nature, 2026
- Expanded protocadherin-1 usage reveals a broader hantavirus entry landscapeWord et al., Journal of Virology, 2026
- Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infectionSlough et al., Nature Communications, 2023
Fluorescent labelling and imaging of viruses
Fluorescent and radiolabelled FSL constructs label influenza, VSV and measles virions directly, for microscopy and in vivo biodistribution studies.
Key papers
- Fluorescein and radiolabeled FSL constructs allow for simple in vitro and in vivo bioimaging of enveloped virionsHadac et al., J Virological Methods, 2011
- Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipidsIlyushina et al., Virologica Sinica, 2014
Virus capture on surfaces
Biotin-labelled virions can be captured on avidin- or receptor-coated surfaces, a route to sensors and immobilised-virus assays.
Key paper
- Rapid one-step biotinylation of biological or non-biological surfacesHenry et al., Scientific Reports, 2018
HIV and pathogen-receptor research
A synthetic Gb3 analogue inhibited HIV-1 infection in vitro. A VSV/HIV pseudotype allows HIV microbicide studies without level 3 biocontainment.
Key papers
- A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanismsHarrison et al., Glycoconjugate Journal, 2010
- A novel VSV/HIV pseudotype approach for the study of HIV microbicidesHarrison et al., Future Virology, 2011
Kode Technology in research reagents and bioengineering
One step labels cells, viruses, liposomes and solid surfaces, with no genetic engineering or chemical conjugation.
The FSL method
The papers that established FSL constructs and how to use them on cell and virion membranes.
Key papers
- Synthetic glycolipid modification of red blood cell membranesFrame et al., Transfusion, 2007
- FSL constructs: a simple method for modifying cell/virion surfaces with a range of biological markersBlake et al., J Visualized Experiments, 2011
- Kode technology: a universal cell surface glycan modification technologyHenry and Bovin, J Royal Society of NZ, 2018
Universal biotinylation
FSL-biotin labels cells, viruses and non-biological surfaces in one step, for streptavidin detection, capture and immobilisation.
Key papers
- Rapid one-step biotinylation of biological or non-biological surfacesHenry et al., Scientific Reports, 2018
- FSL constructs: a simple method for modifying cell/virion surfacesBlake et al., J Visualized Experiments, 2011
Fluorescent cell tracking
Fluorescent FSL constructs label cells without genetic change, for live imaging, flow cytometry and tracking of stored red cells.
Key papers
- Fluorescent FSL construct labelling allows real-time in vivo imaging of cell migration in zebrafishLan et al., Journal of Fluorescence, 2012
- Incorporation of fluorescein FSL constructs into the red blood cell membrane for the duration of ex vivo storageKi et al., J Immunological Methods, 2016
Targeted-cell enrichment for RNA sequencing
FSL-biotin built into therapeutic nanoparticles tags the cells the particles reach, so those cells can be isolated for transcriptomic analysis.
Key paper
- Nanoparticle-based itaconate treatment recapitulates diet-induced atherosclerotic plaque resolutionHong et al., Cell Reports, 2024
Glycan-coated surfaces and nanofibres
FSL glycans coat paper, nanofibres and other non-biological surfaces in seconds, for printed assays and glycan-presenting materials.
Key papers
- Ultra-fast glyco-coating of non-biological surfacesWilliams et al., Int J Molecular Sciences, 2016
- Biofunctionalizing nanofibres with carbohydrate blood group antigensBarr et al., Biopolymers, 2016
Liposomes and self-assembled particles
FSL constructs label liposomes and self-assemble into micelles and core–shell nanoparticles with a controlled ligand density.
Key papers and thesis
- Insertion dynamics of Kode FSL constructs with liposomesCampbell, PhD thesis, Auckland University of Technology, 2023
- Effect of ligand and shell densities on the surface structure of core–shell nanoparticles self-assembled from FSL constructsVaskan et al., Biomaterials Science, 2024
- Structure of supramers formed by the amphiphile biotin-CMG-DOPEZalygin et al., ChemistryOpen, 2020
Kode Technology in glycobiology and immunology
Glycans presented on cells, liposomes or paper in a defined way let researchers study how antibodies, lectins and complement recognise them.
Glycan recognition and antibody fine specificity
Type-specific glycans on kodecytes and paper map which glycan structures an antibody binds, including Lewis, ABH and Forssman antigens.
Key papers
- Antigen presentation in an artificial and cell membrane: blood group A glycan recognitionRyzhov et al., ChemBioChem, 2025
- Glycomapping the fine specificity of monoclonal and polyclonal Lewis antibodies with type-specific kodecytes and FSL constructs on paperWilliams et al., Transfusion, 2016
- FSL constructs of Lewis and chimeric Lewis/ABH glycans: synthesis and use in serological studiesRyzhov et al., Carbohydrate Research, 2016
- Forssman expression on human erythrocytes: evidence of a new histo-blood group systemSvensson et al., Blood, 2013
Lectins, cell adhesion and model membranes
Glycan-coated membranes and vesicles show how lectins bind and how cells and protocells adhere.
Key papers
- Galectin-9 as a potential modulator of lymphocyte adhesion to endothelium via binding to blood group H glycanRapoport et al., Biomolecules, 2023
- Tailor-made Janus lectin with dual avidity assembles glycoconjugate multilayers and crosslinks protocellsRibeiro et al., Chemical Science, 2018
Membrane insertion and lipid rafts
How synthetic glycolipids insert into and leave cell membranes, and how the lipid tail affects it.
Key papers
- Localization of synthetic glycolipids in the cell and the dynamics of their insertion/lossRapoport et al., BBA Biomembranes, 2021
- Raft selectivity of a cholesterol probe capable of forming an H-bond with phospholipidsRyzhov et al., Molecules, 2026
- Influence of the lipid moiety structure on the insertion/release of glycolipids in/from the cellSlivka et al., Russian J Bioorganic Chemistry, 2022
Complement and Fc biology
Kodecytes measure complement-mediated haemolysis and antibody Fc function. Lipid-linked heparan sulfate mimetics are being studied as complement inhibitors.
Key papers
- Antibody complement-mediated hemolytic studies with kodecytesPerry et al., Transfusion, 2016
- An improved Fc function assay utilising CMV antigen coated red blood cellsGeorgakopoulos et al., Vox Sanguinis, 2012
- Synthesis of lipid-conjugated heparan sulfate mimetics and their effect on complement inhibitionRyzhov et al., ChemBioChem, 2026
Endothelium, vesicles and inflammation
Glycan probes on cells and vesicles help study endothelial adhesion, microvesicles and inflammatory cells.
Key papers
- Surface glycans of microvesicles derived from endothelial cells, as probed using plant lectinsSlivka et al., Int J Molecular Sciences, 2024
- Nanoparticle-based itaconate treatment recapitulates diet-induced atherosclerotic plaque resolutionHong et al., Cell Reports, 2024
Kode Technology in therapeutic applications
Kode Technology is being developed for medicine. All therapeutic uses are investigational.
Kode Immunoeducers
Kode Immunoeducers (KIEs) are an adjuvant-like initiator of an in situ autologous cancer vaccine. The KIE supplies the immune-initiating signal; the patient's tumour supplies the tumour antigens.
Key paper
- AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccinesShaw et al., Cancer Cell International, 2019
Other Kode-enabled potential therapeutics
Early research includes liposome modification and lipid-linked heparan sulfate mimetics studied as complement inhibitors.
Key paper
- Synthesis of lipid-conjugated heparan sulfate mimetics and their effect on complement inhibitionRyzhov et al., ChemBioChem, 2026
See the investigational product disclaimer.
Kode Technology publications: every paper
The papers above are a selection. All 101 journal papers and the conference papers are in the Kode Technology bibliography.
Work with us: a new application for Kode Technology
Commission a custom FSL construct, license Kode Technology for a new application, or extend your research with R&D constructs from our catalogue.